Stopping Ozempic or Mounjaro? Here's Your Nutrition Plan
- jadavisr
- 2 days ago
- 7 min read
Nearly 7% of UK adults have already used a GLP-1 medication such as Ozempic, Wegovy or Mounjaro, and a further 8% are considering one, according to a nationally representative survey by the Food Foundation published in January 2026. What happens once the medication stops matters just as much as what happens while someone is taking it, and it receives far less attention.
For some, weight regain begins soon after stopping. That is not a failure of willpower. It reflects physiological changes in appetite hormones, metabolic rate and muscle mass that occur during treatment, none of which reverse simply because the injections stop.
Why Weight Regain Is So Common After Stopping
A 2025 clinical advisory published in the journal Obesity, produced jointly by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society, reviewed the evidence on exactly this question. It found that up to two thirds of the weight lost during GLP-1 treatment can return within a year of stopping, even among people who received nutritional counselling and behavioural support alongside the medication.
The reason lies in how these medications work. GLP-1 medications act on gut hormones and appetite centres in the brain to reduce hunger, slow how quickly food leaves the stomach, and change how the brain responds to food cues. Stop the medication, and those effects fade. Appetite typically returns to, or beyond, where it was before treatment began, while the body's calorie needs remain lower than before because of the weight and muscle already lost.
Appetite returns before new habits are established, and that gap is
where regain most often begins.
What Happens to Muscle During Rapid Weight Loss
In the STEP 1 trial of semaglutide, the average participant lost 13.6kg, and around 38% of that, roughly 5.3kg, was lean body mass rather than fat. Modelling data cited in the same advisory suggest that without structured strength training, muscle loss can account for 10 to 25% of total weight lost, with men typically losing proportionally more than women.
Muscle is metabolically active tissue. Losing it lowers the number of calories the body needs at rest, which makes regain more likely once appetite returns to normal. The same advisory recommends a protein intake of 1.2 to 1.6 grams per kilogram of body weight per day during active weight loss, considerably above the standard reference intake of 0.8 grams per kilogram. In practical terms, this often works out at 80 to 120 grams of protein a day for most adults, though the right figure depends on individual size, health history and activity level. It also recommends structured resistance training at least three times a week, alongside 150 minutes of moderate aerobic activity weekly, specifically to protect muscle and bone during treatment and in the months that follow.
Building a Plan for After You Stop
None of this means the medication was the wrong choice. It means the period after stopping needs the same level of planning as the period on it.
Set a specific daily protein target, generally 1.2 to 1.6g per kilogram of body weight, spread across meals rather than concentrated at dinner.
Keep resistance training in place, at least three sessions a week. This is one of the few interventions shown to meaningfully protect lean mass during and after GLP-1 use.
Reintroduce food volume gradually. Appetite regulation and stomach capacity adjust during treatment, and easing back in reduces the risk of digestive discomfort.
Address nutrient gaps. Reduced intake during treatment is linked to shortfalls in iron, calcium, magnesium, zinc and vitamins A, D, E, K, B1, B12 and C, particularly at very low calorie intakes.
Discuss tapering with your prescriber rather than stopping abruptly. Some evidence suggests spacing doses out gradually, rather than stopping outright, helps retain more of the results, though this decision sits with your GP or prescriber.
Put nutritional support in place before you stop, not after. Outcomes are consistently better when a plan already exists at the point of discontinuation.
Putting This Into Practice After Stopping Ozempic or Mounjaro etc
Building your plate around protein first. Rather than thinking in terms of restriction, structure each meal by starting with a protein source, roughly a palm-sized portion of fish, poultry, eggs, tofu, or a pulse-based option, then building vegetables and a wholegrain or starchy carbohydrate around it. This matters more while appetite is reduced, because protein is the nutrient most easily crowded out of a small meal, and it is the one doing the work of protecting muscle.
How long to stay focused on this. The physiological effects of the medication itself fade over a matter of weeks once dosing stops, semaglutide has a half-life of around a week and clears the body in roughly five weeks, while tirzepatide clears in around 25 to 30 days. But the regain data from the advisory referenced earlier is measured over a full year, not a few weeks, which is the more useful timeframe to plan around. A sensible working guideline is to treat the first three months as the priority window for protein and resistance training, and to keep monitoring habits, weight and energy for the full year rather than assuming the job is done once the injections stop.
Which exercise actually builds and protects muscle. This needs to be resistance training specifically, not general activity, and none of it requires a gym membership. Thirty minutes at home, three times a week, using nothing more than bodyweight or a couple of filled water bottles or tins from the cupboard, covers all the major muscle groups:
Legs: bodyweight squats, adding two water bottles or tins held at the chest for extra resistance once these feel easy; lunges; or simply standing up and sitting back down from a chair repeatedly, which works well as a starting point for anyone less confident with balance.
Chest: press-ups. If a full press-up is too much, a knee press-up (knees on the floor instead of toes) is the next step down, and a wall press-up, hands on a wall instead of the floor, is the easiest starting point. All three work the same muscles.
Back: rows using a resistance band anchored to a door handle, or two tins of beans as light weights, hinging forward slightly and pulling the elbows back; or supermans, lying face down and lifting the arms and legs slightly off the floor.
Shoulders: an overhead press using water bottles or tins, or slow, controlled lateral raises with the same light household weights.
Core: a plank, dropped to the knees if a full plank is too demanding to start; or a bridge, lying on the back and lifting the hips.
Walking around the garden after a dog or cat, or simply being generally on your feet more, is good for overall activity and does not replace this. The muscle-protective effect comes specifically from the resistance work above, not incidental movement, however welcome that movement is.
What about alcohol? Alcohol is not specifically prohibited alongside a GLP-1 medication, but it complicates things in three ways: it can worsen the nausea and reflux that many people already experience, particularly around an injection or a dose increase; it adds calories that work against the deficit the medication is creating; and it can affect blood sugar control. Staying within UK low-risk drinking guidelines, spreading intake across the week rather than concentrating it, avoiding alcohol on an empty stomach, and waiting until any nausea has settled at a given dose are sensible starting points. This becomes more relevant, not less, once the medication stops and appetite returns to normal.
Should you try intermittent fasting? This is worth approaching with caution. Appetite suppression from the medication already creates something close to a fasting pattern without anyone intending it, and deliberately narrowing the eating window further tends to add risk rather than benefit. Protein intake, already under pressure from reduced appetite, becomes harder to hit within a shorter window, working directly against the muscle preservation goal covered earlier. If eating windows are already naturally narrow, the priority is making sure protein and nutrient density are front-loaded within whatever window exists, rather than restricting it further.
How long should tapering take? This is one of the most searched questions on this topic, and there is no single fixed answer. One study presented at the European Congress on Obesity found that tapering semaglutide over an average of nine weeks, rather than stopping in one step, reduced the amount of weight regained. The right schedule depends on current dose, how long the medication has been used, and individual response, which is why it needs to be planned with a prescriber rather than self-managed. What nutrition and exercise can control, regardless of how the taper is structured, is making sure protein intake and strength training are already established before the first dose reduction, not started afterwards.
Questions And Answers About Coming Off a GLP-1 Medication
Will I definitely regain the weight after stopping Ozempic or Mounjaro? Regain is common but not universal or inevitable. The advisory found regain of up to two thirds of lost weight on average, but individual responses vary considerably, and structured nutrition and exercise support after stopping makes a measurable difference to the outcome.
How much protein do I actually need after stopping? Current guidance supports 1.2 to 1.6g per kilogram of body weight per day, roughly 80 to 120g daily for most adults, continued for some months after stopping while the body readjusts.
Do I need to worry about nutrient deficiencies while I'm still on the medication? Reduced food intake during treatment is linked to shortfalls in several nutrients, particularly at very low calorie intakes. A varied, nutrient-dense diet, and testing where appropriate, can catch this early.
Does strength training really make a measurable difference?
Yes. Trial data cited in the advisory shows that combining GLP-1 treatment with structured exercise preserved bone density, while the medication alone did not.
Is there a specific diet I should follow, like keto or the Fast 800? There is no strong evidence to support self-directed very low-calorie or ketogenic diets alongside a GLP-1 medication. A University of Copenhagen trial did use an eight-week, 800-calorie diet before introducing a GLP-1 medication, but that was a structured, supervised protocol within a clinical trial, not something layered onto ongoing GLP-1 treatment unsupervised. A separate real-world study looking at a ketogenic diet combined with a GLP-1 medication found the combination possible under close clinical monitoring, but flagged an increased risk of low blood sugar and noted that clear guidelines for this specific combination do not yet exist. Given the medication already creates a significant calorie deficit and appetite suppression on its own, adding a restrictive named diet on top tends to increase the risk of inadequate protein and nutrient intake rather than improve results. The nutrient-dense, moderate wholefood approach already covered in this piece is what the evidence currently supports.
Stopping a GLP-1 medication is not the end of the process. The evidence is consistent that what happens nutritionally and physically in the months afterwards has a measurable effect on whether the results are maintained. Protecting muscle, meeting protein needs, staying active and having a plan in place before stopping all improve the odds.
If you are thinking about coming off a GLP-1 medication or have already stopped and want support putting a proper nutrition plan in place, book a free thirty minute, no obligation, health chat with me. You can book using the link below and I will phone you on the date & time you choose.
Comments